Expert group consensus from the Arabian Peninsula on the diagnosis of Late Onset Pompe Disease for Orthopedists
![](/.imaging/webp/sanofi-templates/article-hero-w768/dam/campus-sanofi-ae/science-hero-(6).webp/jcr:content/science%20hero%20(6).webp)
Objective and Method
![](/dam/jcr:d7faf808-d647-4c7b-9451-f74a4ff0b0db/Asset%204@4x-100.jpg)
Consensus based on literature supporting clinical presentation and recommendations
Literature Analysis on LOPD Symptoms (Orthopedics): Hierarchy of Evidence
![](/dam/jcr:1f032f5d-14b6-4f77-adb3-0db07a0db72e/Asset%206@4x.jpg)
Orthopedics-Specific
Clinical Presentation for Pediatric/Juvenile* LOPD Proposed During the First Meeting
![](/dam/jcr:5c66aa72-f11d-4d97-bd6b-9922b56bbbe5/bh.jpg)
Orthopedics-Specific
Clinical Presentation for Pediatric/Juvenile* LOPD Proposed During the First Meeting
![](/dam/jcr:8babb90a-a7e2-46ee-ac5a-64d644bd743c/Asset%209@4x.jpg)
Conclusion
![](/dam/jcr:dd10457b-727a-4e9f-a087-c6cf2a9def79/Asset%207@2x.jpg)
Rheumatology-Specific
Recommendation
Testing for Pompe disease must be done if any one specialty-specific symptom plus elevated CK/LDH/ALT/AST or a family history of unexplained muscle weakness is present.
*The age of patients with pediatric/juvenile LOPD ranges from 1 to 17 years.
Abbreviations
ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; CK: Creatine kinase; DBS: Dried blood spot testing; KSA: Kingdom of Saudi Arabia; LDH: Lactate dehydrogenase; LGMW: Limb–girdle muscle weakness; LOPD: Late-onset Pompe disease; UAE: United Arab Emirates.
Reference
- Al Shehri A, Al-Asmi A, Al Salti AM, et al. A multidisciplinary perspective addressing the diagnostic challenges of late-onset Pompe disease in the Arabian Peninsula region developed from an Expert Group Meeting. J Neuromuscul Dis. 2022;9(5):661–673.